PHILADELPHIA - Olfactory Biosciences Corp (OLFC) today announced that it has signed an exclusive distribution agreement with Boxmet Medical sp. z oo, that covers Poland and specific eastern europeoan countries, for its new and improved, all natural formulation for NOXO Odor Defense™ and other NOXO products.
NOXO™ products contain special proprietary formulations of Phytonutrients and Phytochemicals taken from plants, flowers, roots and seeds, designed to have far-reaching applications around the world for people who must endure noxious smells as well those that desire natural wellness products that are non invasive and without side effects.
“All products are immediately available at our offices in Poland and we are excited to provide the needed personal protection for our customers” said Piotr Ambroszczyk. Manager of technical and sales departments.
NOXO™ is a gel, applied topically under the nostrils, specifically formulated to block the physical discomfort, retching, nausea and vomiting associated with offensive and unpleasant odors. NOXO's innovation is to control the effects of offensive and unpleasant odors at the olfactory receptor site in the nose, whereas other products attempt to control bad odors at the source.
Uniquely formulated NOXO Odor Defense™ is based on advanced olfactory perception altering technology developed by Dr. V Ruth Pinney who is a director of Olfactory Biosciences Corp and who also conducts the research for the company's products at her research facility in The Woodlands Texas.
- NOXO Odor Defense™ balm is a blend of proprietary all natural ingredients in a petroleum base and comes in one-dose packets.
- It is simply applied under your nostrils where it immediately begins to trick the brain.
- The scent molecules in the balm impact the olfactory receptors of the brain producing messenger chemicals called neurotransmitters. These act on the limbic system, which regulates perception of odors and other responses in the brain.
- The perception of odor is changed and the odor is masked with a pleasant vanilla scent.
- Real odor elimination technology with NOXO Odor Defense™ balm makes it possible to work comfortably in an atmosphere contaminated with foul odors.
About Boxmet Medical sp. z oo
We are an advanced modern company constantly improving our skills and knowledge so as to benefit our customers. We strive for operational excellence by focusing on the areas of our core competencies - design, manufacture and distribution of high quality, first aid supplies and emergency medical equipment. Strictly controlling production processes, logistics and the values that guide us in day to day activities for our partners in foreign countries in EU. http://www.boxmetmedical.pl/oferta/produkt/334/199
About Olfactory Biosciences Corp.
Olfactory Biosciences Corp.’s NOXO division is focused to develop a variety of products targeting Olfactory Receptors for the desired effect. These alternative medicine wellness products may modify behavior or provide relief to common health problems such as smoking cessation or weight control, as examples. This company has taken NOBEL Prize science related to discoveries of odorant receptors in the nose and the organization of the olfactory system, and has developed unique wellness products that are affordable and made from all natural ingredients. Olfactory Biosciences Corp. offers the most advanced and innovative wellness products with the potential to change the way we approach wellness issues today. Olfactory Biosciences Corp’s unique advantages will make NOXO products the most sought-after wellness products in the alternative medicine market, creating a growth rate ten times higher than most in the this growing category. www.noxoinfo.com/investor
FORWARD-LOOKING STATEMENTS "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding sales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company's products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.
Olfactory Biosciences Corp., Inc.
333 E. Lancaster Ave.
Wynnewood, PA 1909